• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is There (Will There Be) a Post-COVID-19 Chronic Cough?新型冠状病毒肺炎康复后会出现慢性咳嗽吗？
Lung. 2020 Dec;198(6):863-865. doi: 10.1007/s00408-020-00406-6. Epub 2020 Nov 13.
2
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease.轻度和无症状儿童新冠康复后的情况
Lancet Child Adolesc Health. 2021 Jun;5(6):e22-e23. doi: 10.1016/S2352-4642(21)00124-3. Epub 2021 Apr 21.
3
Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.尼日利亚住院 COVID-19 患者出院后症状：一项单中心研究。
Am J Trop Med Hyg. 2021 Jul 16;105(3):731-736. doi: 10.4269/ajtmh.21-0509.
4
Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia.一名新冠康复期肺炎患者出现咯血及新形成的肺大疱
Intern Med. 2021 Mar 1;60(5):803-805. doi: 10.2169/internalmedicine.5684-20. Epub 2021 Jan 15.
5
Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR.土耳其东部 7853 名患者的 10000 个样本中通过实时聚合酶链反应（PCR）检测到 COVID-19 的流行率。
Future Microbiol. 2021 Jul;16(10):697-702. doi: 10.2217/fmb-2020-0134. Epub 2021 Jul 5.
6
COVID-19 in cancer patients can be challenging to screen in a resource limited setting.在资源有限的情况下，对癌症患者中的 COVID-19 进行筛查可能具有挑战性。
Cancer Treat Res Commun. 2020;25:100214. doi: 10.1016/j.ctarc.2020.100214. Epub 2020 Sep 29.
7
Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: a case series in Sinaloa.西纳罗亚州儿童感染 SARS-CoV-2 的临床和流行病学特征：病例系列研究
Bol Med Hosp Infant Mex. 2021;78(1):18-23. doi: 10.24875/BMHIM.200002021.
8
Presence and Duration of Symptoms in Febrile Infants With and Without SARS-CoV-2 Infection.发热婴儿中 SARS-CoV-2 感染与非感染的症状出现与持续时间。
Pediatr Infect Dis J. 2020 Nov;39(11):e372-e374. doi: 10.1097/INF.0000000000002858.
9
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.真正无症状的 SARS-CoV-2 感染可能很少见：仔细访谈和随访的重要性。
J Korean Med Sci. 2020 Sep 21;35(37):e333. doi: 10.3346/jkms.2020.35.e333.
10
Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols.新型冠状病毒（SARS-CoV-2）的空气传播是主要传播途径：飞沫和气溶胶传播。
Infez Med. 2021 Mar 1;29(1):10-19.

引用本文的文献

1
Prevalence and burden of chronic cough in China: results from a population-based survey.中国慢性咳嗽的患病率及负担：基于人群调查的结果
BMC Pulm Med. 2025 May 13;25(1):234. doi: 10.1186/s12890-025-03661-6.
2
AI-boosted and motion-corrected, wireless near-infrared sensing system for continuously monitoring laryngeal muscles.用于持续监测喉部肌肉的人工智能增强且经过运动校正的无线近红外传感系统。
Proc Natl Acad Sci U S A. 2024 Dec 17;121(51):e2410750121. doi: 10.1073/pnas.2410750121. Epub 2024 Dec 9.
3
Development of a Comprehensive Cough Therapy Program (CCTP) for chronic cough in India: a qualitative study.印度慢性咳嗽综合咳嗽治疗方案（CCTP）的制定：一项定性研究。
Codas. 2024 Oct 11;36(6):e20230347. doi: 10.1590/2317-1782/20242023347en. eCollection 2024.
4
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study.意大利慢性咳嗽的患病率、临床特征和疾病负担：一项横断面研究。
BMC Pulm Med. 2024 Jun 20;24(1):288. doi: 10.1186/s12890-024-03095-6.
5
Prevalence and burden of chronic cough in France.法国慢性咳嗽的患病率及负担
ERJ Open Res. 2024 Apr 8;10(2). doi: 10.1183/23120541.00806-2023. eCollection 2024 Mar.
6
The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature.肠道-大脑轴在 COVID-19 康复患者神经症状发展中的作用：假说与文献综述。
Front Cell Infect Microbiol. 2022 Dec 22;12:983089. doi: 10.3389/fcimb.2022.983089. eCollection 2022.
7
Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis.新冠长期患者中慢性疲劳综合征的全球患病率：一项系统评价和荟萃分析。
Biopsychosoc Med. 2022 Oct 23;16(1):21. doi: 10.1186/s13030-022-00250-5.
8
Pathophysiology of Post-COVID syndromes: a new perspective.新冠后综合征的病理生理学：新视角。
Virol J. 2022 Oct 9;19(1):158. doi: 10.1186/s12985-022-01891-2.
9
Prevalence and risk factors for postinfectious cough in discharged patients with coronavirus disease 2019 (COVID-19).2019冠状病毒病（COVID-19）出院患者感染后咳嗽的患病率及危险因素
J Thorac Dis. 2022 Jun;14(6):2079-2088. doi: 10.21037/jtd-21-876.
10
Searching for Factors Influencing the Severity of the Symptoms of Long COVID.探寻影响长新冠症状严重程度的因素。
Int J Environ Res Public Health. 2022 Jun 30;19(13):8013. doi: 10.3390/ijerph19138013.

本文引用的文献

1
Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia.胸部X线检查对重症新型冠状病毒肺炎幸存者的呼吸道症状和功能损害预测能力较差。
ERJ Open Res. 2021 Feb 8;7(1). doi: 10.1183/23120541.00655-2020. eCollection 2021 Jan.
2
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort.COVID-19 住院患者的预后及其随访意义：来自英国前瞻性队列研究的结果。
Thorax. 2021 Apr;76(4):399-401. doi: 10.1136/thoraxjnl-2020-216086. Epub 2020 Dec 3.
3
ACE2: The Major Cell Entry Receptor for SARS-CoV-2.血管紧张素转化酶 2：SARS-CoV-2 的主要细胞进入受体。
Lung. 2020 Dec;198(6):867-877. doi: 10.1007/s00408-020-00408-4. Epub 2020 Nov 10.
4
Acute activation of bronchopulmonary vagal nociceptors by type I interferons.I 型干扰素对肺支气管迷走神经伤害感受器的急性激活。
J Physiol. 2020 Dec;598(23):5541-5554. doi: 10.1113/JP280276. Epub 2020 Sep 27.
5
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.COVID-19 患者使用激肽 B2 受体拮抗剂的相关结局。
JAMA Netw Open. 2020 Aug 3;3(8):e2017708. doi: 10.1001/jamanetworkopen.2020.17708.
6
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
7
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
8
A lesson from a saboteur: High-MW kininogen impact in coronavirus-induced disease 2019.从破坏者身上吸取的教训：高 MW 激肽原在冠状病毒病 2019 中的作用。
Br J Pharmacol. 2020 Nov;177(21):4866-4872. doi: 10.1111/bph.15154. Epub 2020 Jun 30.
9
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications.COVID-19 呼吸并发症中血管紧张素转化酶 2 下调作用的假设。
FASEB J. 2020 Jun;34(6):7265-7269. doi: 10.1096/fj.202000967. Epub 2020 May 2.
10
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.COVID-19 患者的激肽释放酶-激肽系统阻断治疗以预防急性呼吸窘迫综合征。
Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555.

Is There (Will There Be) a Post-COVID-19 Chronic Cough?

作者信息

Dicpinigaitis Peter V, Canning Brendan J

机构信息

Albert Einstein College of Medicine and Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA.

Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA.

出版信息

Lung. 2020 Dec;198(6):863-865. doi: 10.1007/s00408-020-00406-6. Epub 2020 Nov 13.

DOI:10.1007/s00408-020-00406-6
PMID:33188436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7665087/
Abstract
摘要